India's Dishman Carbogen surges on posting Q2 profit
** Shares of Dishman Carbogen Amcis DSHM.NS rise 16.2% to
208 rupees
** The pharma co posted Q2 consol net PAT of 330.9 mln
rupees ($3.9 mln) vs loss of 409 mln rupees a year ago; rev from
ops rose 35% Y/Y
** Co says earnings were helped by higher commercial sales
and rollover of some shipments which got pushed to Q2 from Q1
** More than 6.1 mln shares change hands, 13.2X its 30-day
avg
** Stock up 20% YTD
($1 = 84.4025 Indian rupees)
(Reporting by Ashna Teresa Britto in Bengaluru)
((AshnaTeresa.Britto@thomsonreuters.com))
Recent news on Dishman Carbogen Amcis
See all newsBrief: Dishman Carbogen Amcis Approves Raising Of Funds Via NCDs Worth Up To 380 Million Rupees
India's Dishman Carbogen Amcis falls after posting quarterly loss
Brief: Dishman Carbogen Amcis June-Quarter Consol Net Loss 578.8 Million Rupees
Brief: Dishman Carbogen Amcis Says Unit Successfully Completed GMP Inspection By China's NMPA For Shanghai Site
Brief: Dishman Carbogen Amcis Ltd Approves Issue Of Up To 1 Billion Rupees NCDs On Private Placement Basis